| Sep 3 |
Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 30 |
Femasys secures CE mark certification for FemVue MINI solution
|
| Aug 29 |
Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution
|
| Aug 27 |
Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters
|
| Aug 10 |
Femasys Second Quarter 2024 Earnings: Misses Expectations
|
| Aug 9 |
Femasys reports Q2 results
|
| Aug 8 |
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 8 |
Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update
|
| Jun 27 |
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam
|
| Jun 21 |
Femasys gains CE Mark approval for women’s health products
|
